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The aim is to examine whether the changes in pleural ﬂuid interleukin (IL)-1β, IL-2, IL-6, and IL-8 levels were signiﬁcant in diﬀer-
ential diagnosis of childhood pleural eﬀusions. IL-1β, IL-2, IL-6, and IL-8 levels in pleural ﬂuids of all 36 patients were measured.
The levels of IL-1β, IL-2, IL-6, and IL-8 in pleural ﬂuids were statistically signiﬁcantly higher in the transudate group compared
with those of the exudate group. The levels of IL-1β, IL-6, and IL-8 were also found to be statistically signiﬁcantly higher in the
empyema group compared with both the parapneumonic and the tuberculous pleural eﬀusion groups. The levels of IL-2 and IL-6
were detected to be statistically signiﬁcantly higher in the tuberculous pleural eﬀusion group in comparison with those of the para-
pneumonic eﬀusion group. The results showed that pleural ﬂuids IL-1β, IL-2, IL-6, and IL-8 could be used in pleural ﬂuids exudate
and transudate distinction.
INTRODUCTION
Pleura is divided into a parietal layer which lines the
inner aspect of the chest wall and a visceral layer which
covers the interlobar ﬁssures. These two layers are sepa-
rated with a cavity containing 5–15mL ﬂuid. Fluid collec-
tion within the pleural cavity can be assessed with clini-
cal and radiological means. When pleural eﬀusion is de-
tected, the characteristics of the ﬂuid (exudate or transu-
date)mustberevealedusingthoracocentesis.Pneumonias
and congestive heart failure are the most frequently en-
countered causes of transudative and exudative eﬀusions,
respectively [1].
Inﬂammation develops on the ground of the complex
mechanism of cytokine discharges. Accumulating knowl-
edge about cytokines demonstrated their important roles
in the pathogenesis of most of the infectious diseases [2].
Interleukins (ILs) mediate the reactions of the our organ-
ism against foreign antigens and harmful agents. The ILs
act through autocrine or paracrine rather than endocrine
pathways. In various infectious diseases signiﬁcant alter-
ationsinILconcentrationsofblood,aswellasofbodyﬂu-
ids, occur. Although IL levels in serum and various body
ﬂuids have been studied in various diseases, very few re-
searches involving IL levels in pleural eﬀusions of chil-
dren have been conducted [3, 4]. It is already acknowl-
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edged that established criteria used for the diﬀerentiation
between exudative and transudative pleural eﬀusions in
adults are not valid for children and further studies are
required to determine diagnostic criteria for children [5].
T h ea i mo ft h i ss t u d yi st oc o m p a r eI Ll e v e l si ne x u d a t i v e
and transudative pleural ﬂuids by measuring IL levels in
pleural eﬀusions developed owing to various etiological
factors in childhood. We aimed to examine whether the
changes in pleural ﬂuid protein, glucose, and lactate de-
hydrogenase (LDH) parameters, as well as in IL-1β,I L - 2 ,
IL-6, and IL-8 levels, were signiﬁcant in diﬀerential diag-
nosis of childhood pleural eﬀusions.
MATERIALS AND METHODS
The study group consisted of 26 patients admitted
in the Department of Pediatrics, Medical Faculty, Firat
University with a diagnosis of pleural eﬀusions. Thora-
cal ultrasonograms were obtained from patients thought
to have pleural eﬀusions in consideration of medical his-
tory, physical examination, and chest X-rays. The pres-
ence and the amount of pleural ﬂuids were determined
andthenthoracocentesiswasperformed.Allsampleswere
obtained by thoracentesis at the diagnosis time (Table 1,
Figure 1). Pleural ﬂuids were collected in three separate
tubes. The collected samples were evaluated as for color
and appearance (turbidity). The ﬁrst samples were cen-
trifuged immediately for the measurement of IL concen-
tration and the supernatant layers were stored at −70◦C
until testing for cytokines. The second samples were in-
oculated in aerobic, anaerobic, and L¨ owenstein-Jensen2005:1 (2005) Cytokine Levels in Pleural Eﬀusions 3
Table 1. The demographic features of all groups.
Groups Study group (n(%)) Age (year, mean ± SE) Gender (F/M)
Transudates 9 (25) 7.1 ±0.95 / 4
Exudates 27 (75) 5.1 ±0.68 / 1 9
Parapneumonic 12 (44) 5.4 ±0.84 / 8
Empyema 12 (44) 4.2 ±0.83 / 9
Tuberculous 3 (12) 8.5 ±3.51 / 2
Total 36 5.6 ±0.5 13/23
Pleural eﬀusion
Transudates Exudates
Pleural protein < 3g/dL Pleural protein > 3g/dL
Pleural LDH < 200IU/L Pleural LDH > 200IU/L
Pleural ﬂuid/serum protein < 0.5 Pleural ﬂuid/serum protein > 0.5
Pleural ﬂuid/serum LDH < 0.6 Pleural ﬂuid/serum LDH > 0.6
Empyema Parapneumonic Tuberculosis
Pleural ﬂuid bacterial culture (+) Pleural ﬂuid glucose > 40mg/dL Pleural ﬂuid tuberculosis culture (+)
Pleural ﬂuid glucose < 40mg/dL Pleural ﬂuid bacterial culture (−) Pleural ﬂuid AFB (+)
and/or
Pleural ﬂuid protein > 5g/dL
Responded favorably to the
antituberculosis treatment
and/or
pH < 7.1
Figure 1. The source and the type of pleural eﬀusion samples.
media and stained with Gram, Giemsa, and Ziehl-Nielsen
dyes. The third samples were analysed for protein, glu-
cose, and LDH. As indicators of infection, peripheral
leukocyte counts (WBC), erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP) measurements, blood
culture, and puriﬁed protein derivate (PPD) tests were
performed.SerumtotalproteinandLDHlevelsweremea-
sured. Acid fast bacilli (AFB) were cultivated in fasting
gastric secretions.
Pleural eﬀusions were categorized as exudates and
transudates according to the clinical and laboratory ﬁnd-
ings. Light’s criteria were used to diﬀerentiate between
transudates and exudates [5]. The cutoﬀ values for the
diﬀerentiation between the pleural transudates and exu-
dates were determined as follows: protein, 3g/dL; LDH,
200IU/L; pleural ﬂuid/serum protein ratio, 0.5; and pleu-
ral ﬂuid/serum LDH ratio, 0.6. Pleural eﬀusions with val-
ues above these cutoﬀs were classiﬁed as exudates and
thosebelow astransudates.Exudateswerealsogroupedas
empyematous, parapneumonic, or tuberculous eﬀusions.
Empyematous eﬀusions were characterised by the pres-
ence of Gram-positive bacteria in pleural ﬂuid smears,
attendant pneumonia with or without bacterial growth
in the cultures of pleural ﬂuid samples, and typical glu-
cose (< 40mg/dL) and/or protein (> 5g/dL) and/or
LDH (> 1000IU/L), and pH (< 7.1) values. The sam-
ples of pleural ﬂuids with higher glucose concentrations
(> 40mg/dL) whose Gram-stained smears did not reveal
any speciﬁc characteristics or bacterial growth were con-
sidered as parapneumonic eﬀusions. The patients whose
pleuralﬂuidsmearsrevealedAFBwhichcouldbecultured
inL¨ owenstein-Jensenmediaandalsorespondedfavorably
to the antituberculostatic treatment were acknowledged
as cases with tuberculous pleurisy [5, 6, 7].
Pleural ﬂuids preserved at −70◦Cw e r et h a w e da n d
IL-1β, IL-2, IL-6, and IL-8 levels in the samples were
measured using enzyme-linked immunosorbent assay
(ELISA) and IL-1β, IL-2, IL-6, and IL-8 Bender Medsys-
tems commercial kits.
The clinical and laboratory characteristics of the
patients were given as means (± standard deviation
(SD)). Statistical evaluations between diﬀerent groups
weredonewithKruskal-Wallisvarianceanalysisandpost-
hoc Tukey-Scheﬀe tests using SPSS 10.0 software pro-
grams.
RESULTS
In our study group pleural eﬀusions were of exuda-
tive (n = 27, 75%) and transudative (n = 9, 25%) type.4 Saadet Akarsu et al 2005:1 (2005)
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Figure 2. The levels of blood acute phase reactants in the study
groups.
The ages of the study subjects ranged between 9 months
and 14 years. Twelve parapneumonic (44%), 12 empye-
matous (44%), and 3 (12%) tuberculous pleural eﬀusions
were detected in the exudate group (Table 1).
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Figure 3. The levels of pleural ﬂuids biochemical characteristics
in the study groups.
A statistically signiﬁcant diﬀerence was found be-
tween CRP values of the exudate (140.2 ± 92.4mg/dL)
and the transudate (9.6 ± 3.2mg/dL) groups (P<. 001)
(Figure 2). LDH concentrations in pleural ﬂuids were2005:1 (2005) Cytokine Levels in Pleural Eﬀusions 5
1828.9 ±1835.6U/L in the exudate and 89.8±20.3U/Lin
the transudate groups (P<. 001). Protein levels in pleural
ﬂuids were measured as 5.1 ± 1.2g/dLand1.6 ± 0.5g/dL
in the exudate and the transudate groups, respectively
(P<. 001). Glucose levels in pleural ﬂuids were mea-
sured as 53.3 ± 36.6mg/dL in the exudate group and
83.8±14.7mg/dLinthetransudategroup(P<. 001)(Fig-
ure 3).
IL-1β levels of pleural ﬂuids in the exudate and the
transudate groups were detected as 304.1 ± 127.7pg/mL
and 70.1 ±23.4p g / m L ,r e s p e c t i v e l y( P<. 001). IL-1β lev-
els were demonstrated as 210 ± 43.5pg/mL in the para-
pneumonic eﬀusion group, 430.3 ± 69.9pg/mL in the
empyematous eﬀusion group, and 175.3 ± 36.3pg/mLin
the tuberculous eﬀusion groups. Statistically signiﬁcantly
higher values were found in the empyematous group
when compared with the parapneumonic and tubercu-
lous pleural eﬀusion groups (P<. 001).
IL-2 concentrations of pleural ﬂuids were ascertained
to be at undetectable levels in 12 (44.4%) and 176.6 ±
173.6pg/mLin15(55.6%) patients in the exudate group.
These concentrations were wholly at undetectable lev-
els in the transudate group. Statistically signiﬁcant diﬀer-
ence was uncovered between the exudate and the transu-
date groups (P<. 001). Statistically signiﬁcant diﬀerences
were not revealed between the empyematous group and
the other two groups (P>. 05). Statistically signiﬁcantly
higher values were recognized in the tuberculous pleural
eﬀusion group rather than the parapneumonic eﬀusion
group (P<. 01).
IL-6levelsweredetectedtobe18589.5±3631.8pg/mL
in the exudate group and 65.6 ± 16.0pg/mL in the tran-
sudate group (P<. 001). The corresponding values were
15295.0 ± 22678.1pg/mL in the parapneumonic eﬀu-
sion group, 20518.0 ± 1410.9pg/mL in the empyema-
tous eﬀusion group and 24050.0 ± 223.3pg/mL in the
tuberculous pleural eﬀusion group. In the empyematous
group, statistically signiﬁcantly higher values were ob-
tained when compared with those of the parapneumonic
eﬀusion group, while the corresponding values detected
in the tuberculous pleural eﬀusion group were also sig-
niﬁcantly higher than those found in the parapneumonic
eﬀusion group (P<. 001).
IL-8 levels of pleural ﬂuids were assessed to be
3068.5 ± 1762.7pg/mL in the exudate group and 108.8 ±
92.0pg/mL in the transudate group (P<. 001). The con-
centrations of IL-8 were 1884.5 ± 366.7 in the parap-
neumonic eﬀusion group, 4789.8 ± 1013.2pg/mL in the
empyematous eﬀusion group and 919.0 ± 9454.5pg/mL
in the tuberculous pleural eﬀusion group. The values
were statistically signiﬁcantly higher in the empyematous
group when compared with the other two groups (P<
.001) (Figure 4).
DISCUSSION
Pleural eﬀusion is most frequently seen during the
course of pneumonias. Pleural eﬀusion can be seen due to
theintrusionofaninfectiousagentoranirritatingforeign
substance inside the pleural cavity or due a direct access
of harmful materials or neoplastic cells into the pleural
cavity via hematogenous route [8]. It can be observed fol-
lowingpleuraltraumaorinassociationwithasbestosisre-
lated pleural diseases. Pleural eﬀusion or empyema in as-
sociation with pneumonia is relatively frequent [8]. Pleu-
ral eﬀusions are known to develop secondary to trauma,
cardiac, renal, collagenous diseases and malignancies be-
sides pneumonia [9, 10, 11]. From 61% to 80% of the
cases with pleural eﬀusions are of infectious origin. De-
spite the usage of broad spectrum antibiotics, empyema
continues to be an important health care problem during
childhood. Empyema is also an important cause of mor-
tality in the developing countries. In the remaining 20%–
39%ofthecases,empyemadevelopssecondarytotrauma,
malignancies, and renal diseases [5, 12, 13, 14, 15]. In our
study group an infectious agent was responsible for 75%
of the cases. Many studies have been conducted concern-
ing the levels of IL-1β, IL-2, IL-6, and IL-8 in body ﬂuids
invariousinfections.Althoughmanystudiesinvestigating
the alterations in levels of IL according to the exudative
or transudative nature of pleural eﬀusions in adults have
been performed, similar studies pertaining to children are
relatively few [16, 17, 18].
IL-1β which is a proinﬂammatory cytokine plays a
key role in various infections. For that reason many stud-
ies have analysed IL-1β levels in patients with meningi-
tis, sepsis, urinary tract infections, and empyema. Vari-
ableresultshavebeenobtaineddependentonthepresence
of diﬀerent etiological agents [17, 18]. In patients with
bacterial and tuberculous meningitis, IL-1β levels of cere-
brospinal ﬂuids were found to be signiﬁcantly higher than
those with aseptic meningitis and in the control group.
UmblicalplasmalevelsofIL-1βofinfectednewbornswith
early-onset sepsis were found to be higher than those of
the control group. IL-1β levels in synovial ﬂuids were de-
tected to be higher than those in the pediatric cases with
suppurativearthritisduetoothercauses.Silva-Mejiasetal
[18] have found comparatively higher IL-1β levels in the
empyema group. Similar to our ﬁndings, Alexandrakis et
al [19] revealed that IL-1β levels in pleural eﬀusions were
higher in the exudate group compared with those of the
transudate group. Naito et al [20] ascertained that IL-1β
levels in pleural eﬀusions were higher than those found
in bacterial infections due to other causes. In accordance
with the literature in our study, IL-1β levels were nearly
4.5 times higher in the exudate group.
IL-2 levels in pleural eﬀusions due to malignancies
were reported to be lower than those with tuberculous
pleural eﬀusions [21]. Shimokata et al [22] stated that
IL-2 levels were at undetectable levels in 25% of tuber-
culous pleural eﬀusions and 75% of cancerous pleural ef-
fusions. In our study IL-2 levels in pleural ﬂuids were at
undetectably lower levels in 44% of the patients in the ex-
udate group while the IL-2 levels of the remaining 56%
were assessed as 176.6 ± 33.4pg/mL. However all the pa-
tients in the transudate group demonstrated undetectable6 Saadet Akarsu et al 2005:1 (2005)
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Figure 4. The levels of pleural ﬂuids IL-1β, IL-2, IL-6, and IL-8 in patients with diﬀerent etiologic diagnosis in the exudate and
transudate groups.
IL-2 levels. In our study a statistically signiﬁcant diﬀer-
ence was not present between the empyema group and
the other two groups. However a statistically signiﬁcant
diﬀerence was detected between the parapneumonic and
the parapneumonic pleural eﬀusion groups.
Various studies have been performed concerning the
levels of IL-6 which is the mediator and the regulator of
inﬂammatory responses in miscellaneous inﬂammatory
processes. Blood IL-6 levels were found to be higher in
children with Mycoplasma pneumoniae infections who
stayed febrile for more than 3 days compared with those
having shorter febrile episodes [16]. They were also statis-
tically signiﬁcantly higher in pediatric cases with urinary
tract infections when compared with the control groups.
IL-6 levels of cerebrospinal ﬂuid in the patients with bac-
terial meningitis were reported to be signiﬁcantly higher
than the aseptic meningitis and in the control groups.
Blood IL-6 levels above 100pg/mL were measured in pe-
diatric cases with viral (14%) but especially with bacterial
meningitis (53%). Xirouchaki et al [23]a n dY o k o y a m a
et al [24] reported the levels of IL-6 in pleural ﬂuids to
be signiﬁcantly higher in the exudate group rather than
the transudate group. They also found IL-6 concentra-
tions signiﬁcantly higher in the tuberculous group rather
than the parapneumonic eﬀusion group. In our study
not only the levels of IL-6 were diﬀerent between the
groups with parapneumonic and empyematous eﬀusions,
but at the same time statistically signiﬁcant diﬀerences
were found between the empyematous and the parapneu-
monic or tuberculous pleural eﬀusion groups. Alexan-
drakis et al [25]m e a s u r e dI L - 6l e v e l si ns e r u ma n dp l e u -
ral ﬂuids and ascertained that serum IL-6 levels did not
diﬀer signiﬁcantly between the exudate and the transu-
date groups. However pleural ﬂuid IL-6 levels were de-
tected to be meaningfully higher in the exudate rather
than the transudate group. A deﬁnite proportion between
the serum and pleural ﬂuid IL-6 concentrations could not
be assessed. However we found IL-6 levels in the pleural2005:1 (2005) Cytokine Levels in Pleural Eﬀusions 7
ﬂuid to be 285 times higher than those detected in the ex-
udate group.
IL-8 is the mediator and the regulator of chemo-
taxis of leukocytes in inﬂammatory processes. In adults
miscellaneous studies have analysed IL-8 levels in pleu-
ral ﬂuids. IL-8 levels were found to be higher in cases
with infectious pleural eﬀusions compared with the pa-
tients with noninfectious eﬀusions [3, 26, 27, 28, 29,
30, 31, 32]. Ceyhan et al [26] reported higher levels
in empyematous/parapneumonic eﬀusion groups rather
than the tuberculous group. However Antony et al [28]
detected higher levels in cases with parapneumonic ef-
fusions unlike those found in the group with tubercu-
lous eﬀusions. IL-8 concentrations in the empyematous
group were reported to be higher than those measured
in the parapneumonic group. In accordance with this
study, in our study the highest levels of IL-8 were de-
tected in the empyematous, parapneumonic, and tuber-
culous pleural eﬀusions in decreasing order. Dlugovitzky
et al [29] discovered statistically signiﬁcantly higher IL-8
values in the tuberculous pleural eﬀusion group in con-
trast with ﬁndings in the parapneumonic pleural eﬀusion
group. Ashitani et al [30] and Broaddus et al [32]f o u n d
higher levels in the empyema group compared with the
other groups. Miller and Idell [31] have detected signiﬁ-
cantly higher levels in the exudate group rather than the
transudate group. In this study, similar to the ﬁndings of
other investigations, IL-8 levels in the exudate group were
reported to be 28 times higher than those found in the
transudate group.
This study have shown that for the diﬀerentiation be-
tween the exudative and transudative pleural eﬀusions, in
addition to the parametres such as protein, glucose and
LDH, pleural ﬂuid IL-1β, IL-2, IL-6, and IL-8 levels could
be used. Etiological factors can be diﬀerentiated by deter-
miningpleuralﬂuidILlevels.Takingtheselevelsintocon-
sideration, the exudative or transudative nature of pleural
ﬂuidscanbeascertained.Accordingly,adeﬁnitivediagno-
sis, a successful treatment and reduction in mortality can
be achieved.
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